Lv2
156 积分 2024-02-28 加入
Auristatin S: An Auristatin Payload with Improved Tolerability and Modified Bystander Activity
1天前
已完结
New payloads drive next-gen antibody–drug conjugates
1天前
已完结
Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 1: Synthesis of Two Oligopeptide Fragments
4天前
已完结
Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 1: Synthesis of Two Oligopeptide Fragments
5天前
已完结
Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody–Drug Conjugates with Self-Immolative Disulfide Linkers
9天前
已完结
Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates
9天前
已完结
Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody–Drug Conjugates
9天前
已完结
Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and In Vivo
19天前
已完结
Case Study: Irinotecan (CPT-11), A Water-soluble Prodrug of SN-38
20天前
已完结
Abstract PR015: Discovery of LY4050784 (FHD-909), a selective BRM (SMARCA2) ATPase inhibitor for the treatment of BRG1(SMARCA4) mutant cancers
21天前
已完结
皖公网安备34019202002308
